How viruses contribute to the pathogenesis of hemophagocytic lymphohistiocytosis

Frontiers in Immunology

Volumn 8, Issue SEP, 2017, Pages

  Brisse, Ellen ^a   Wouters, Carine H ^a,b   Andrei, Graciela ^a   Matthys, Patrick ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

DNA viruses; Hemophagocytic lymphohistiocytosis; Herpesviruses; Immuno evasion; Infection; Macrophage activation syndrome; Pathogenesis

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE; CHEMOKINE; CHEMOKINE RECEPTOR AGONIST; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 6; JANUS KINASE INHIBITOR; LATENT MEMBRANE PROTEIN 1; PATTERN RECOGNITION RECEPTOR; RUXOLITINIB; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; TUMOR NECROSIS FACTOR; VIRAL PROTEIN; VIRUS GLYCOPROTEIN;

ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE MARROW DEPRESSION; CYTOTOXIC T LYMPHOCYTE; DNA VIRUS; EXOCYTOSIS; HEMATOPOIETIC STEM CELL; HEMOPHAGOCYTIC SYNDROME; HERPESVIRIDAE; HUMAN; IMMUNE DEFICIENCY; IMMUNE EVASION; IMMUNOMODULATION; INFLUENZA A (H1N1); INFLUENZA A VIRUS (H5N1); INNATE IMMUNITY; MICROTUBULE; MOLECULAR MIMICRY; NATURAL KILLER CELL; NONHUMAN; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TH1 TH2 BALANCE; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS LATENCY;

EID: 85029000517     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01102     Document Type: Article

References (83)

1. Janka GE, Lehmberg K. Hemophagocytic syndromes -an update. Blood Rev (2014) 28(4):135-42. doi:10.1016/j.blre.2014.03.002
2. Vaiselbuh SR, Bryceson YT, Allen CE, Whitlock JA, Abla O. Updates on histiocytic disorders. Pediatr Blood Cancer (2014) 61(7):1329-35. doi:10.1002/pbc.25017
3. Sieni E, Cetica V, Hackmann Y, Coniglio ML, Da Ros M, Ciambotti B, et al. Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning. Front Immunol (2014) 5:1-19. doi:10.3389/fimmu.2014.00167
4. Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood (2010) 116(7):1079-82. doi:10.1182/blood-2010-01-256099
5. Sumegi J, Seemayer TA, Huang D, Davis JR, Morra M, Gross TG, et al. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses. Leuk Lymphoma (2002) 43(6):1189-201. doi:10.1080/10428190290026240
6. Zhang K, Jordan MB, Marsh RA, Johnson JA, Kissell D, Meller J, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood (2011) 118(22):5794-8. doi:10.1182/blood-2011-07-370148
7. Zhang K, Chandrakasan S, Chapman H, Valencia CA, Husami A, Kissell D, et al. Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. Blood (2014) 124:1331-4. doi:10.1182/blood-2014-05-573105
8. Zhang M, Behrens EM, Atkinson TP, Shakoory B, Grom AA, Cron RQ. Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep (2014) 16(9):439-46. doi:10.1007/s11926-014-0439-2
9. Sepulveda FE, Garrigue A, Maschalidi S, Garfa-Traore M, Ménasché G, Fischer A, et al. Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice. Blood (2016) 127(17):2113-21. doi:10.1182/blood-2015-12-688960
10. Meeths M, Bryceson YT. HLH susceptibility: genetic lesions add up. Blood (2016) 127(17):2051-2. doi:10.1182/blood-2016-03-700609
11. Cetica V, Sieni E, Pende D, Danesino C, De Fusco C, Locatelli F, et al. Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry. J Allergy Clin Immunol (2016) 137(1):188-96.e4. doi:10.1016/j.jaci.2015.06.048
12. Bode SFN, Ammann S, Al-Herz W, Bataneant M, Dvorak CC, Gehring S, et al. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Haematologica (2015) 100(7):978-88. doi:10.3324/haematol.2014.121608
13. Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood (2015) 125(19):2908-15. doi:10.1182/blood-2015-01-551622
14. Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood (2004) 104(3):735-43. doi:10.1182/blood-2003-10-3413
15. Pachlopnik Schmid J, Ho C-H, Chrétien F, Lefebvre JM, Pivert G, Kosco-Vilbois M, et al. Neutralization of IFNγamma defeats haemophagocytosis in LCMV-infected perforin-and Rab27a-deficient mice. EMBO Mol Med (2009) 1(2):112-24. doi:10.1002/emmm.200900009
16. Chen M, Felix K, Wang J. Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation. Blood (2012) 119(1):127-36. doi:10.1182/blood-2011-06-363994
17. Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders. Cytokine Growth Factor Rev (2015) 26:263-80. doi:10.1016/j.cytogfr.2014.10.001
18. Humblet-Baron S, Franckaert D, Dooley J, Bornschein S, Cauwe B, Schönefeldt S, et al. IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol (2016) 138(1):200-09.e8. doi:10.1016/j. jaci.2015.12.1314
19. Zoller EE, Lykens JE, Terrell CE, Aliberti J, Filipovich AH, Henson PM, et al. Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med (2011) 208(6):1203-14. doi:10.1084/jem.20102538
20. Jordan M, Locatelli F, Allen C, De Benedetti F, Grom AA, Ballabio M, et al. A novel targeted approach to the treatment of hemophagocytic lymphohistiocytosis (HLH) with an anti-interferon gamma (IFNγ) monoclonal antibody (mAb), NI-0501: first results from a pilot phase 2 study in children with primary HLH. Blood (2015) 126(23):LBA-3.
21. Canna SW, Wrobel J, Chu N, Kreiger PA, Paessler M, Behrens EM. Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice. Arthritis Rheum (2013) 65(7):1764-75. doi:10.1002/art.37958
22. Brisse E, Imbrechts M, Put K, Avau A, Mitera T, Berghmans N, et al. Mouse cytomegalovirus infection in BALB/c mice resembles virus-associated secondary hemophagocytic lymphohistiocytosis and shows a pathogenesis distinct from primary hemophagocytic lymphohistiocytosis. J Immunol (2016) 196:3124-34. doi:10.4049/jimmunol.1501035
23. Milner JD, Orekov T, Ward JM, Cheng L, Torres-Velez F, Junttila I, et al. Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation. Blood (2010) 116(14):2476-83. doi:10.1182/blood-2009-11-255174
24. Burn TN, Rood JE, Weaver L, Kreiger PA, Behrens EM. Murine hemophagocytic lymphohistiocytosis can occur in the absence of interferon-gamma. J Immunol (2016) 196(1 Suppl) 126.5.
25. Tesi B, Sieni E, Neves C, Romano F, Cetica V, Cordeiro AI, et al. Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFNγ? receptor deficiency. J Allergy Clin Immunol (2015) 135(6):1638-41. doi:10.1016/j.jaci.2014.11.030
26. Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH, Simmons RL, et al. Virus-associated hemophagocytic syndrome. Cancer (1979) 44:993-1002. doi:10.1002/1097-0142(197909)44:3<993::AID-CNCR2820440329> 3.0.CO;2-5
27. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis (2007) 7:814-22. doi:10.1016/S1473-3099(07)70290-6
28. Rosado FGN, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol (2013) 139(6):713-27. doi:10.1309/AJCP4ZDKJ4ICOUAT
29. George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med (2014) 5:69-86. doi:10.2147/JBM.S46255
30. Li F, Yang Y, Jin F, Dehoedt C, Rao J, Zhou Y, et al. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J Rare Dis (2015) 10(20):1-9. doi:10.1186/s13023-015-0224-y
31. Cattaneo C, Oberti M, Skert C, Passi A, Farina M, Re A, et al. Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients. Hematol Oncol (2016). doi:10.1002/hon.2314
32. Ahn J-S, Rew S-Y, Shin M-G, Kim H-R, Yang D-H, Cho D, et al. Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol (2010) 85(9):719-22. doi:10.1002/ajh.21795
33. Teramura T, Tabata Y, Yagi T, Morimoto A, Hibi S, Imashuku S. Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis. Leuk Lymphoma (2002) 43:173-9. doi:10.1080/10428190210176
34. Münz C, Lünemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol (2010) 9(4):246-58. doi:10.1038/nri2527
35. Ascherio A, Munger KL. EBV and autoimmunity. In: Münz C, editor. Epstein Barr Virus Volume 1, One Herpes Virus: Many Diseases Current Topics in Microbiology and Immunology. Cham: Springer International (2015). p. 365-85.
36. Descamps FJ, Van den Steen PE, Nelissen I, Van Damme J, Opdenakker G. Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes. Adv Exp Med Biol (2003) 535:69-77. doi:10.1007/978-1-4615-0065-0_5
37. Alcami A, Koszinowski UH. Viral mechanisms of immune evasion. Trends Microbiol (2000) 8(9):410-8. doi:10.1016/S0966-842X(00)01830-8
38. Dunmire SK, Odumade OA, Porter JL, Reyes-Genere J, Schmeling DO, Bilgic H, et al. Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes. PLoS One (2014) 9(1):e85422. doi:10.1371/journal.pone.0085422
39. Behrens EM, Canna SW, Slade K, Rao S, Kreiger PA, Paessler M, et al. Repeated TLR9 stimulation results in macrophage activation syndrome -like disease in mice. J Clin Invest (2011) 121(6):2264-77. doi:10.1172/JCI43157
40. Ohyagi H, Onai N, Sato T, Yotsumoto S, Liu J, Akiba H, et al. Monocyte-derived dendritic cells perform hemophagocytosis to fine-tune excessive immune responses. Immunity (2013) 39(3):584-98. doi:10.1016/j.immuni.2013.06.019
41. Pascutti MF, Erkelens MN, Nolte MA. Impact of viral infections on hematopoiesis: from beneficial to detrimental effects on bone marrow output. Front Immunol (2016) 7:364. doi:10.3389/fimmu.2016.00364
42. Brown KE, Young NS. Parvoviruses and bone marrow failure. Stem Cells (1996) 14(2):151-63. doi:10.1002/stem.140151
43. Crow MS, Lum KK, Sheng X, Song B, Cristea IM, Crow MS, et al. Diverse mechanisms evolved by DNA viruses to inhibit early host defenses. Crit Rev Biochem Mol Biol (2016) 51(6):452-81. doi:10.1080/10409238.2016.1226250
44. Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBVassociated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood (2001) 98(6):1882-8. doi:10.1182/blood. V98.6.1882
45. Mao H, Tu W, Qin G, Law HKW, Sia SF, Chan P-L, et al. Influenza virus directly infects human natural killer cells and induces cell apoptosis. J Virol (2009) 83(18):9215-22. doi:10.1128/JVI.00805-09
46. Terrell CE, Jordan MB. Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells. Blood (2013) 121:5184-91. doi:10.1182/blood-2013-04-495309
47. Ansari A, Li S, Abzug MJ, Weinberg A. Human herpesviruses 6 and 7 and central nervous system infection in children. Emerg Infect Dis (2004) 10(8):1450-4. doi:10.3201/eid1008.030788
48. Lusso P, Malnati MS, Garzino-Demo A, Crowley RW, Long EO, Gallo RC. Infection of natural killer cells by human herpesvirus 6. Nature (1993) 362:458-62. doi:10.1038/362458a0
49. Lusso BP, Garzino-demo A, Crowley RW, Malnati MS. Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J Exp Med (1995) 181(1):1303-10. doi:10.1084/jem.181.4.1303
50. Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus. J Virol (1997) 71(10):7963-8.
51. Orange JS, Fassett MS, Koopman LA, Boyson JE, Strominger JL. Viral evasion of natural killer cells. Nat Immunol (2002) 3(11):1006-12. doi:10.1038/ni1102-1006
52. Puttur FK, Fernandez MA, White R, Roediger B, Cunningham AL, Weninger W, et al. Herpes simplex virus infects skin T cells before langerhans cells and impedes migration of infected langerhans cells by inducing apoptosis and blocking E-cadherin downregulation. J Immunol (2010) 185(1):477-87. doi:10.4049/jimmunol.0904106
53. Abendroth A, Morrow G, Cunningham AL, Slobedman B. Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host. Society (2001) 75(13):6183-92. doi:10.1128/JVI.75.13.6183-6192.2001
54. Groux H, Cottrez F, Montpellier C, Quatannens B, Coll J, Stehelin D, et al. Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus. Blood (1997) 89(12):4521-30.
55. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL. Viral subversion of the immune system. Annu Rev Immunol (2000) 18:861-926. doi:10.1146/annurev.immunol.18.1.861
56. Fox A, Nguyen L, Hoa M, Horby P, van Doorn HR, Trung NV, et al. Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses. PLos One (2012) 7(2):e31535. doi:10.1371/journal.pone.0031535
57. Luppi M, Torelli G. The new lymphotropic herpesvirusses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview. Haematologica (1996) 81:265-81.
58. Jenkins MR, Rudd-Schmidt JA, Lopez JA, Ramsbottom KM, Mannering SI, Andrews DM, et al. Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med (2015) 212(3):307-17. doi:10.1084/jem.20140964
59. Weitzman MD, Ornelles DA. Inactivating intracellular antiviral responses during adenovirus infection. Oncogene (2005) 24:7686-96. doi:10.1038/sj.onc.1209063
60. Lee HR, Brulois K, Wong LY, Jung JU. Modulation of immune system by Kaposi's sarcoma-associated herpesvirus: lessons from viral evasion strategies. Front Microbiol (2012) 3:1-14. doi:10.3389/fmicb.2012.00044
61. Brinkmann MM, Dag F, Hengel H, Messerle M, Kalinke U, Cicin-Šain L. Cytomegalovirus immune evasion of myeloid lineage cells. Med Microbiol Immunol (2015) 204(3):367-82. doi:10.1007/s00430-015-0403-4
62. Odom CI, Gaston DC, Markert JM, Cassady KA. Human herpesviridae methods of natural killer cell evasion. Adv Virol (2012) 2012:1-10. doi:10.1155/2012/359869
63. Chuang H-C, Lay J-D, Hsieh W-C, Wang H-C, Chang Y, Chuang S-E, et al. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood (2005) 106(9):3090-6. doi:10.1182/blood-2005-04-1406
64. Palendira U, Low C, Chan A, Hislop AD, Ho E, Phan TG, et al. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol (2011) 9(11):e1001187. doi:10.1371/journal.pbio.1001187
65. Hsieh S, Chang S. Cutting edge: insufficient perforin expression in CD8+ T cells in response to hemagglutinin from avian influenza (H5N1) virus. J Immunol (2006) 176:4530-3. doi:10.4049/jimmunol.176.8.4530
66. Mao H, Tu W, Liu Y, Qin G, Zheng J, Chan PL, et al. Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J Virol (2010) 84(9):4148-57. doi:10.1128/JVI.02340-09
67. Xu A, Bellamy AR, Taylor JA. Immobilization of the early secretory pathway by a virus glycoprotein that binds to microtubules. EMBO J (2000) 19(23): 6465-74. doi:10.1093/emboj/19.23.6465
68. Sepulveda FE, Maschalidi S, Vosshenrich CAJ, Garrigue A, Kurowska M, Ménasche G, et al. A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice. Blood (2016) 125(9):1427-34. doi:10.1182/blood-2014-09-602946
69. See DM, Khemka P, Sahl L, Bui T, Tilles JG. The role of natural killer cells in viral infections. Scand J Immunol (1997) 46:224-317. doi:10.1046/j.1365-3083.1997.d01-121.x
70. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol (2003) 3(1):36-50. doi:10.1038/nri980
71. Cox MA, Kahan SM, Zajac AJ. Anti-viral CD8 T cells and the cytokines that they love. Virology (2013) 435(1):157-69. doi:10.1016/j.virol.2012.09.012
72. Polizzotto MN, Uldrick TS, Wang V, Aleman K, Wyvill KM, Marshall V, et al. Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood (2013) 122(26):4189-74198. doi:10.1182/blood-2013-08-519959
73. Das R, Guan P, Sprague L, Verbist K, Tedrick P, An QA, et al. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Blood (2016) 127(13):1666-75. doi:10.1182/blood-2015-12-684399
74. Maschalidi S, Sepulveda FE, Garrigue A, Fischer A, de Saint Basile G. Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice. Blood (2016) 128(1):60-72. doi:10.1182/blood-2016-02-700013
75. Suthaus J, Stuhlmann-Laeisz C, Tompkins VS, Rosean TR, Klapper W, Tosato G, et al. HHV8 encoded viral IL-6 collaborates with mouse IL-6 in MCD-like development in mice. Blood (2012) 119(22):5173-82. doi:10.1182/blood-2011-09-377705
76. Strippoli R, Carvello F, Scianaro R, De Pasquale L, Vivarelli M, Petrini S, et al. Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome. Arthritis Rheum (2012) 64(5):1680-8. doi:10.1002/art.33496
77. Cifaldi L, Prencipe G, Caiello I, Bracaglia C, Locatelli F, De Benedetti F, et al. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome. Arthritis Rheumatol (2015) 67(11):3037-46. doi:10.1002/art.39295
78. Brinkmann MM, Schulz TF. Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae. J Gen Virol (2006) 87(5):1047-74. doi:10.1099/vir.0.81598-0
79. Ma Y, Li X, Kuang E. Viral evasion of natural killer cell activation. Viruses (2016) 8(95):1-14. doi:10.3390/v8040095
80. Liu J, Zhan W, Kim CJ, Clayton K, Zhao H, Lee E, et al. IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses. PLoS One (2014) 9(2):e89236. doi:10.1371/journal.pone.0089236
81. Zhou C, Xie Z, Gao L, Liu C, Ai J, Zhang L. Profiling of EBV-encoded microRNAs in EBV-associated hemophagocytic lymphohistiocytosis. Tohoku J Exp Med (2015) 237(56):117-26. doi:10.1620/tjem.237.117
82. Lee WI, Lin JJ, Hsieh MY, Lin SJ, Jaing TH, Chen SH, et al. Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection. PLoS One (2013) 8(10):e76711. doi:10.1371/journal.pone.0076711
83. Lo AK, To KF, Lo KW, Lung RWM, Hui JWY, Liao G, et al. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci U S A (2007) 104(41):16164-9. doi:10.1073/pnas.0702896104